2000 · Devices & clinical
Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries
Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV.
Neurosurgery 47(2):335-43; discussion 343-5, 2000.
PMID 10942006 · DOI 10.1097/00006123-200008000-00013
In plain language
Cerebral hyperperfusion syndrome is a complication thought to come from excess blood flow into the brain after a narrowed artery is opened. It was a known complication of carotid surgery, seen in 0.3 to 1.2% of cases, but how often it follows angioplasty and stenting was unknown.
The authors reviewed 140 patients who had angioplasty or stenting of arteries to the brain between 1996 and 2000. Seven (5.0%) developed signs of the syndrome after a delay. Six had brain swelling on the treated side, including two with bleeding. Symptoms resolved within 72 hours in the four without bleeding, while the two with bleeding recovered over 3 weeks to 6 months. There were no long-term effects or deaths.
The authors recommend close monitoring of blood pressure, heart rate and blood thinning after these procedures.
A plain-language summary for patients and families. It is not medical advice, and individual results vary.
Abstract
Objective
Cerebral hyperperfusion syndrome is a recognized complication of carotid endarterectomy, with a reported incidence of 0.3 to 1.2%. The incidence of cerebral hyperperfusion after endovascular revascularization procedures of the craniocervical arteries remains unknown. We evaluated the incidence of cerebral hyperperfusion syndrome in our endovascular revascularization series. To our knowledge, there are no previous studies evaluating the incidence of hyperperfusion syndrome after percutaneous transluminal angioplasty/stenting.
Methods
Between March 1996 and February 2000, 140 patients underwent percutaneous transluminal angioplasty/stenting of the craniocervical arteries at our institution. In all patients, selective bilateral arteriography of the carotid and vertebral arteries was performed to document the sites of craniocervical stenosis and collateral blood flow and the results of the endovascular revascularization procedure. We then reviewed all pertinent medical records, arteriographic films, and sectional imaging studies to determine the incidence of cerebral hyperperfusion in this series.
Results
Seven patients (5.0%) developed clinical or radiological manifestations of cerebral hyperperfusion. In the target group, percutaneous transluminal stenting achieved a 90 to 100% reduction in stenotic lesions (mean stenosis, 91%) of the carotid (n = 5) and vertebral (n = 2) arteries. All seven patients remained neurologically stable immediately after treatment. There was delayed development of clinical and radiographic findings, suggestive of cerebral hyperperfusion. Six patients showed evidence of ipsilateral hemispheric edema, including two patients who developed intracranial hemorrhage (one parenchymal, one parenchymal and subarachnoid) documented by computed tomographic brain scans. Symptoms resolved within 72 hours in the four patients without hemorrhage. The two patients with hemorrhage recovered during a more protracted period (range, 3 wk to 6 mo). There were no long-term sequelae or deaths during a cumulative follow-up of 84 months (mean follow-up, 12 mo).
Conclusion
Hyperperfusion syndrome is an uncommon but potentially serious complication of extracranial and intracranial angioplasty and stenting procedures. The clinical manifestations are similar to hyperperfusion syndrome after carotid endarterectomy; however, the prevalence may be greater in the high-risk cohort commonly referred for endovascular treatment. Our findings suggest that patients undergoing endovascular stenting procedures should be closely monitored for evidence of hyperperfusion, with careful monitoring of blood pressure, heart rate, and anticoagulation. Further research is needed to confirm that cerebral hyperperfusion is the pathogenesis of this condition.
Abstract as indexed in PubMed (PMID 10942006). Copyright the publisher.
Cite this paper
Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery 47(2):335-43; discussion 343-5. 2000. doi:10.1097/00006123-200008000-00013 PMID: 10942006.